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Abstract
Background: Decreasing side effects and improving the quality of block in caesarean sections by appropriate dosage of local anes-
thetics and adjuvants could play an important role in the safe management of cesarean section. The present study aimed at compar-
ing the effects of 3 different doses of intrathecal hyperbaric bupivacaine injected with a fixed dose of sufentanil in cesarean sections.
Methods: In a double- blind randomized clinical trial, 105 candidates of elective cesarean section were randomly assigned into 3
groups of 8, 9, and 10 mg of intrathecal bupivacaine plus sufentanil 2.5 µg. The maximum level of sensory block, the intensity of
motor block, and vital signs were measured at regular intervals. The incidence of hypotension and bradycardia were also recorded.
Results: No significant difference was found between the maximum level of sensory block and the intensity of motor block in
3 groups. The incidences of hypotension and bradycardia as well as administration of atropine and ephedrine were comparable
among the 3 groups (P > 0.05).
Conclusions: According to similar effects of different doses of bupivacaine, administration of lower doses of bupivacaine (8mg) is
more reasonable for spinal anesthesia for cesarean section.
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1. Background
Spinal anesthesia is the most common method of anes-
thesia for caesarean section. Administration of an appro-
priate dose and combination of local anesthetics could
minimize the possible side effects and simultaneously im-
prove the quality of block (1, 2). Hyperbaric bupivacaine
with proper use of adjutants has been considered as ac-
ceptable common method of spinal anesthesia in caesar-
ian section (3, 4). Several studies have reported that the
combination of low dose local anesthetics and opioids
in spinal anesthesia have the advantage of shorter onset
times and higher quality of the blocks (5, 6).
Spinal anesthesia with any combination is likely to
cause adverse effects such as hypotension, bradycardia,
and shortness of breath, nausea, and vomiting. However,
by adding opioids such as sufentanil to bupivacaine, the
required dose of local anesthetic is decreased. This may
result in lower side effects and improved quality of spinal
anesthesia and postoperative analgesia (7, 8). Earlier stud-
ies have examined the effects of adding various amounts of
sufentanil to a fixed dose of local anesthetic to find the op-
timum dose of adjuvant (9-12). This study was conducted to
evaluate the effects of different doses of bupivacaine com-
bined with a fixed acceptable dose of sufentanil to find a
prescription for a safe and high quality spinal anesthesia
for cesarean section.
2. Methods
2.1. Study Protocol
In this double- blind, randomized clinical trial, 126 can-
didates of elective cesarean section were recruited. Of
them, 21 patients were excluded during the study and the
remaining 105 were randomly allocated into 3 groups of
spinal anesthesia with bupivacaine 8, 9, or 10 mg plus
sufentanil 2.5 µg. Block randomization was used to assign
equal number of patients in each group. The level of spinal
block, duration of sensory and motor block, and hemo-
dynamic variables were compared among the 3 groups.
Both the patients and the assessor were blinded to the as-
signments. The local ethics committee approved the study
protocol, and informed consent was obtained from all pa-
tients. The study was registered in clinical trials registry
(IRCT2017010931852N1).
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The inclusion criteria were as follow: candidates of
elective cesarean section after 36 weeks of gestation,
height more than 150 cm, no history of addiction, no his-
tory of pre-eclampsia, eclampsia, or hypertension, and no
contraindication for spinal anesthesia. Patients with tech-
nical failure were excluded.
2.2. Intervention andMeasurements
Standard monitoring was implemented, and then, the
patients were hydrated with ringer’s lactate solution 5
mL.kg-1. Spinal anesthesia was performed at the fowler’s
position through lower lumbar intervertebral spaces us-
ing Quinke needle size 25. Patients were randomly allo-
cated to the spinal anesthesia with 8, 9, or 10 mL of hy-
perbaric Bupivacaine 0.5% (AstraZeneca Company, France)
plus 2.5 µg of sufentanil (Abu Rayhan Company, Iran).
Drugs were administered with a 3 mL syringe (3MED, Iran
Medical Equipment, Tehran, Iran) to facilitate the dose ad-
justments. Injection was performed at a constant rate of
0.2 mL/sec. Afterwards, patients were immediately placed
in the supine position.
Spinal anesthesia hemodynamic parameters and sen-
sory and motor block were measured at 5, 10, 15, 20, 30, 60,
90, 120, and 150 minutes. Sensory block was evaluated with
pin prick method and motor block with Bromage score (Ta-
ble 1). Assessment for sensory and motor block was contin-
ued in 30- minute intervals until full regression of block-
ade. Side effects such as nausea, vomiting, hypotension,
bradycardia, and itching were recorded. Bradycardia was
defined as slowing heart rate of more than 30% of individ-
ual baseline or less than 60 beats per minute. Atropine 0.5
mg per dose was administered to treat bradycardia. Simi-
larly, hypotension was considered when the mean arterial
pressure (MAP) decreased to more than 30% of baseline or
less than 70 mmHg. Hypotension was treated with incre-
mental intravenous doses of ephedrine.
Table 1. Description of the Bromage Score
Grade Criteria Degree of Block, (%)
I Free movement of legs and feet Nil (0)
II Just able to flex knees with free
movement of feet
Partial (33)
III Unable to flex knees, but with free
movement of feet
Almost complete (66)
IV Unable to move legs or feet Complete (100)
2.3. Statistical Analysis
Data were presented as mean (standard deviation), me-
dian (25, 75 percentile) or frequency (percentage), as ap-
propriate. The normal distribution of quantitative vari-
ables was assessed with Kolmogorov-Smirnov test. To com-
pare quantitative variables in the 3 groups, ANOVA or
Kruskal-Wallis test were used, as appropriate. Qualitative
variables were compared with chi square test. Significance
level was set at P < 0.05. Data were analyzed using statis-
tical package for social sciences software (SPSS Company,
Chicago, Il) Version 22.
3. Results
The demographic variables and the ASA class of pa-
tients were comparable among the 3 groups. Patients were
37 ± 7 years on average with the mean gestational age of
37.2 ± 1.2 week. In all 3 groups, spinal block was success-
ful and no high neuraxial block (level higher than T4) was
recorded. The patients in the 10 mg group showed higher
degrees of motor block. However, the difference was not
statistically significant (Table 2). No significant difference
was found between the maximum level of sensory block
(or duration of recovery from sensory) and motor block in
the 3 groups (P > 0.05) (Tables 3 and 4). The complication
rates including the need for atropine or ephedrine admin-
istration, nausea, vomiting, and pruritus were not signif-
icantly different among the 3 groups (Table 4). The trend
of blood pressure and heart rate was comparable in the 3
groups (P > 0.05) (Figures 1 and 2).
4. Discussion
All the 3 doses of intrathecal bupivacaine showed simi-
lar satisfactory block profiles. Generally, previous studies
yielded comparable results with some trivial differences.
An earlier study evaluated the effects of intrathecal bupiva-
caine (6, 8, and 10 mg plus sufentanil 3µg) in cesarean sec-
tion surgery; this study reported similar motor block in the
3 groups, but it was found that with the increase in the dose
of bupivacaine, the level of sensory block increased and the
time of reaching the maximum motor block intensity de-
creased. On the other hand, increasing the dose of bupiva-
caine resulted in higher incidence of nausea, hypotension,
and the need for ephedrine (13).
An earlier study suggested that adding sufentanil to in-
trathecal bupivacaine will reduce the required dose of lo-
cal anesthetic in parturient. Nevertheless, they examined
rather higher doses of bupivacaine (14). Another study re-
ported that the maximum level of sensory block in cae-
sarean patients who received bupivacaine 6 mg plus sufen-
tanil 3.3 µg is comparable to those patients that received
bupivacaine 12 mg without adjuvant. This will also reduce
the incidence of hypotension and the need for ephedrine
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Figure 1. The Trend of MAP in Patients in Three Groups
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Figure 2. The Trend of Heart Rate in Three Groups
Table 2. Intensity of Motor Block in Three Groups from Spinal Anesthesia Until Dischargea
Time, Min Dose of Bupivacaine P Value
8mg 9mg 10mg
Immediately after spinal anesthesia 2 (2,3) 2 (2,3) 3 (2,3) 0.733
5 4 (3,4) 4 (4,4) 4 (4,4) 0.318
10 4 (4,4) 4 (4,4) 4 (4,4) 0.139
15 4 (4,4) 4 (4,4) 4 (4,4) 0.333
20 4 (4,4) 4 (4,4) 4 (4,4) 0.333
30 4 (4,4) 4 (4,4) 4 (4,4) 0.602
60 4 (4,4) 4 (4,4) 4 (4,4) 0.093
90 4 (3,4) 4 (4,4) 4 (3,4) 0.521
120 2 (2,3) 2 (2,3) 3 (2,3) 0.389
150 2 (1,2) 1 (1,2) 3 (2.5,3.5) 0.137
aData are presented as Median (25,75 percentile).
administration (15). Controversies to our findings may be
attributed to the lower prescribed doses of local anesthetic
in our patients.
4.1. Study Limitations
Inability to blind the anesthetist who performed spinal
anesthesia was a limitation. However, both the assessor
and the patients were blinded to the assignments. Another
limitation was that we did not evaluate the extra require-
ment for analgesics in the postoperative period.
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Table 3. Maximum Level of Sensory Block in 3 Groups from Spinal Anesthesia Until Dischargea
Time, Min Dose of Bupivacaine P Value
8mg 9mg 10mg
Immediately after spinal Anesthesia 8 (8,10) 8 (8,10) 8 (8,10) 0. 88
5 6 (6,6) 6 (6,6) 6 (6,6) 0.982
10 6 (6,6) 6 (6,6) 6 (6,6) 0.974
15 6 (6,6) 6 (6,6) 6 (6,6) 0.979
20 6 (6,6) 6 (6,6) 6 (6,6) 0.971
30 6 (6,6) 6 (6,6) 6 (6,6) 0.845
60 6 (6,6) 6 (6,6) 6 (6,6) 0.409
90 6 (6,8) 6 (6,7) 6 (6,8) 0.491
120 10 (8,11.5) 8 (8,10) 8 (6,10) 0.166
150 12 (10,12) 11 (10,12) 10 (10,12) 0.252
aValues correspond to the level of spinal anesthesia (i.e., 8 represents 8th thoracic level) and presented as Median (25,75 percentile).
Table 4. Duration of Recovery from Sensory and Motor Block, and the Rate of Complications in Three Groupsa
Variable Dose of Bupivacaine P Value
8mg 9mg 10mg
Recovery from sensory block,min 110± 17 116± 15 110± 18 0.875
Recovery frommotor block,min 107± 28 115± 17 116± 20 0.708
Atropine administration 7 (20) 9 (25.7) 9 (25.7) 0.809
Ephedrine administration 12 (34.3) 12 (34.3) 15 (42.9) 0.826
Nausea 7 (20) 7 (20) 9 (25.7) 0.65
Vomiting 4 (11.4) 5 (14.3) 4 (11.4) 0.92
Pruritus 4 (11.4) 8 (22.9) 5 (14.3) 0.826
aData are presented as mean± SD or No. (%)
Taken together, it seems that replacing a small amount
of intrathecal bupivacaine with sufentanil favorably re-
duces the incidence of complications; namely, hypoten-
sion and nausea, while provides an acceptable profile of
spinal anesthesia. The recommended dose of intrathecal
bupivacaine ranged from 6 to 12.5 mg in earlier studies. In
this study, increasing the dose of bupivacaine from 8 mg
to 10 mg, when combined with sufentanil administration,
did not considerably affect the maximum level of sensory
block, intensity of motor block, or the duration of recovery
from sensory and motor block. Thus, a lower dose of bupi-
vacaine seems to be a more reasonable choice. In conclu-
sion, bupivacaine doses of 6 to 8 mg with added sufentanil
may provide the best results with minimal side effects in
cesarean section surgery.
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